Advances in the classification and treatment of isolated superior mesenteric artery dissection.
10.3760/cma.j.cn112139-20220516-00225
- Author:
Chao Chen WANG
1
;
Yu Dong SUN
2
;
Xiao Long WEI
1
;
Zai Ping JING
1
;
Zhi Qing ZHAO
1
Author Information
1. Department of Vascular Surgery, Changhai Hospital, Naval Medical University, Shanghai 200433, China.
2. Department of General Surgery, Jinling Hospital, Nanjing University, Nanjing 210002, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Mesenteric Artery, Superior;
Treatment Outcome;
Tomography, X-Ray Computed;
Aortic Dissection/therapy*;
Stents;
Endovascular Procedures;
Retrospective Studies
- From:
Chinese Journal of Surgery
2023;61(1):81-85
- CountryChina
- Language:Chinese
-
Abstract:
Isolated superior mesenteric artery dissection (ISMAD) has attracted more and more clinicians' attention in recent years. Patients onset of ISMAD often present with abdominal pain. The misdiagnosis or miss diagnosis is common because of the non-specific symptoms and signs, which even can endanger lives in serious cases. Imaging classification is of great significance for diagnosis and treatment of ISMAD. The Sakamoto classification and the Yun classification are two classical classified methods. However, with the further study of ISMAD, various new classifications emerge. Conservative treatment was once considered as the preferred. As the rapid development of endovascular therapy and the great progress of new devices, stenting therapy can significantly improve symptoms and achieve satisfactory long-term effects, and be even expected to become the preferred method for clinical therapy of ISMAD. However, the long-term effects of endovascular therapy still need a large number of follow-up data, and complications after stent implantation can't be ignored.
